NR3C1 and cancer: The in silico predicted cytotoxic activity of progestins, glucocorticoids, and diclofenac has been experimentally confirmed on hormone-dependent Hep-2, HeLa, MCF-7, and K-562 cancer cell lines, which contain both progesterone and glucocorticoid receptors.